慢性非特异性部疼痛的放松技术:系统性审查和元分析
Julián Ángel Basco-López1, Eva Rodríguez-Gutiérrez2, Ana Torres-Costoso1
1Faculty of Physiotherapy and Nursing, University of Castilla-La Mancha.
概括
与没有治疗相比,放松技术有效减少慢性非特异性部疼痛 (CNNP) 和残疾. 然而,与CNNP的物理治疗干预相比,它们没有显著差异.
科学领域:
- 疼痛管理 疼痛管理
- 康复医学 康复医学 康复医学
- 行为医学是一种行为医学.
背景情况:
- 慢性非特异性部疼痛 (CNNP) 是一种普遍的疾病,对生活质量产生重大影响.
- 保守的干预措施是有前途的,但CNNP放松技术的具体有效性仍未得到充分研究.
研究的目的:
- 评估放松技术对CNNP患者疼痛强度和与疼痛相关的残疾的有效性.
- 将放松技术与物理治疗干预和控制条件进行比较.
主要方法:
- 针对随机对照试验,对五个数据库进行系统的文献搜索,截至2023年11月.
- 使用随机效应模型进行元分析,以汇集标准化平均差异和95%置信区间.
- 超回归来探索参与者和干预特征的影响.
主要成果:
- 包括16项研究,涉及1384名患有CNNP的成年人.
- 放松技术与物理治疗对于疼痛强度 (SMD = -0.14) 或残疾 (SMD = -0.02) 并没有显著不同.
- 与对照条件相比,放松技术显著降低了疼痛强度 (SMD = -0.48) 和残疾 (SMD = -0.45).
结论:
- 放松技术是CNNP康复的可行的治疗选择,比对照组显示出适度的益处.
- 在治疗CNNP的放松技术和物理治疗干预措施之间没有发现显著差异.
- 进一步的研究可能会探索放松技术在综合康复计划中的最佳整合.
相关概念视频
Classification of Skeletal Muscle Relaxants
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Relaxation of Skeletal Muscles
The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open.


